Galapagos NV to Develop Medicines in New Strategy Published: Jan 26, 2010 Reuters -- Belgian biotechnology company Galapagos plans to develop its own products at its own cost and risk in a "important change of strategy", its Chief Executive told a Dutch daily on Tuesday. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news